Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

414
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
414
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

990
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
990
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

660
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
660
Anatomy of the Genitourinary System II: Bladder and Urethra01:19

Anatomy of the Genitourinary System II: Bladder and Urethra

3.3K
The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...
3.3K
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

389
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
389
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.4K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Global Consensus Conference on Surgical Management of Primary Uterovaginal Prolapse and Lower Urinary Tract Dysfunction: Combining Evidence with Expert Opinion.

International urogynecology journal·2026
Same author

Unequal Utilization of Overactive Bladder Treatment: The Role of Socioeconomic and Insurance Disparities.

Neurourology and urodynamics·2026
Same author

Patients' Perspectives and Challenges with Sacral Neuromodulation Implantable Pulse Generator.

International urogynecology journal·2026
Same author

Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence.

Nature reviews. Urology·2026
Same author

Navigating the challenges of overactive bladder management in women.

World journal of urology·2026
Same author

Satisfaction and Decisional Regret After Mesh Versus Non-Mesh Apical Pelvic Organ Prolapse Surgery.

Neurourology and urodynamics·2026

Related Experiment Video

Updated: Apr 21, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

25.7K

An update on the pharmacotherapy for lower urinary tract dysfunction.

Nitya Abraham1, Howard B Goldman

  • 1Montefiore Medical Center, Department of Urology , Bronx, NY USA.

Expert Opinion on Pharmacotherapy
|October 30, 2014
PubMed
Summary

This review details pharmacotherapies for lower urinary tract (LUT) conditions like overactive bladder, underactive bladder, stress urinary incontinence, and bladder outflow obstruction, emphasizing individualized treatment plans.

Keywords:
bladder outflow obstructioniatrogenic obstructionoveractive bladderpharmacotherapystress urinary incontinenceunderactive bladderurgency incontinence

More Related Videos

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K
Real-Time Void Spot Assay
06:39

Real-Time Void Spot Assay

Published on: February 10, 2023

2.7K

Related Experiment Videos

Last Updated: Apr 21, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

25.7K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K
Real-Time Void Spot Assay
06:39

Real-Time Void Spot Assay

Published on: February 10, 2023

2.7K

Area of Science:

  • Urology
  • Pharmacology
  • Neuroscience

Background:

  • The lower urinary tract (LUT) manages urine storage and voiding, controlled by complex neural pathways.
  • Pharmacological interventions aim to modulate LUT neural control in pathological conditions.

Purpose of the Study:

  • To review current pharmacotherapies for various lower urinary tract dysfunctions.
  • To categorize medications based on the specific LUT condition they treat.

Main Methods:

  • Review of pharmacologic agents for overactive bladder, including antimuscarinics and beta-adrenergic agonists.
  • Examination of limited treatments for underactive bladder, such as muscarinic agonists.
  • Analysis of medications for stress urinary incontinence and bladder outflow obstruction, including alpha-adrenergic agents and PDE inhibitors.

Main Results:

  • Established pharmacotherapies exist for overactive bladder and stress urinary incontinence.
  • Effective pharmacotherapy for underactive bladder remains a challenge.
  • Multiple drug classes are available for bladder outflow obstruction.

Conclusions:

  • Lower urinary tract pharmacotherapy requires personalized selection based on patient-specific factors.
  • Individualized treatment considers symptom severity, side effects, comorbidities, and insurance.
  • This review provides a comprehensive overview of current LUT medical therapies.